The anti-allergy and anti-inflammatory effect of Anemarrhenae Rhizoma invivo and in vitro > Volume 07 - 2007

본문 바로가기

사이트 내 전체검색

 » New Articles(2011~Present)
 » Articles (2001~2010)
      ∙ Volume 10 - 2010
      ∙ Volume 09 - 2009
      ∙ Volume 08 - 2008
      ∙ Volume 07 - 2007
      ∙ Volume 06 - 2006
      ∙ Volume 05 - 2005
      ∙ Volume 04 - 2004
      ∙ Volume 03 - 2003
      ∙ Volume 02 - 2002
      ∙ Volume 01 - 2001

Oriental Pharmacy and Experimental Medicine
Volume 07 - 2007
Date: 2007

Journal: Pages 235-243

September 2007 | The anti-allergy and anti-inflammatory effect of Anemarrhenae Rhizoma invivo and in vitro…

Su-Jin Kim1,3, Hyun-Ja Jeong1,3, Noh-Yil Myung2,3, Phil-Dong Moon4, Ju-Young Lee5, Byoung-Jae Yi2,Eun-Hyub Lee2, Nyeon-Hyung An2, Seok-Jae Park2, Min-Cheol Kim2,3, Suk-Min Jun2, Ji-Hyun Lee2,Hyung-Min Kim4, Seung-Heon Hong2 and Jae-Young Um1,*



​Anemarrhenae Rhizoma (AR) is used in traditional oriental medicine for various medicinal purposes.However, the exact mechanism that accounts for the anti-allergy and anti-inflammatory effects of the ARis still not fully understood. The aim of the present study is to elucidate whether and how AR modulatesthe allergic reactions in vivo, and inflammatory reaction in vitro. In this study, we showed that ARsignificantly decreased compound 48/80-induced systemic anaphylaxis, paw oedema, and histaminerelease from preparation of rat peritoneal mast cells. Also, AR inhibited the expression ofinflammatory cytokine in PMA plus A23187-stimulated human mast cells (HMC-1). In addition, weshowed that anti-inflammatory mechanism of AR is through suppression of nuclear factor-κBactivation and IκB-α degradation. These results provided new insight into the pharmacologicalactions of AR as a potential molecule for therapy of inflammatory allergic diseases.

This website Copyright (c) 2014 Institute of Korean Medicine Kyung Hee University All rights reserved.
Top View
Mobile View